DB

Dimple Bhanushali

Active Director Director DIN 08609256
DIN 08609256 First appointment Nov 2019 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 5 active board seats
Past companies 1 historical roles
Total affiliations 6 Since Nov 2019
Shareholding value •••• Premium profile

About Dimple Bhanushali

Data last updated:

Dimple Bhanushali is a Director at Clinico Pet Scan Private Limited (since 2021), Director at Clinico Scan Centre Private Limited (since 2019) and Designated Partner at Shree Pharmacy Llp (since 2022), and holds 2 more current directorships. The companies operate in Healthcare and Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹14.92 Cr; the largest is Clinico Pet Scan Private Limited at ₹10.59 Cr (FY 2025). Earlier, Dimple Bhanushali was a Director at Benediction Healthcare Private Limited (2024–2025).

DIN 08609256
Primary Designation Director
Industry Healthcare
First Appointment 11 Nov 2019
Oldest Company Age 7 yrs
Largest company Clinico Pet Scan Private Limited · ₹10.59 Cr (FY 2025)
Combined revenue ₹14.92 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Clinico Pet Scan Private Limited U85100MH2021PTC359849
Director04 May 20212021₹10.59 Cr (FY 2025)Active
Clinico Scan Centre Private Limited U85100MH2019PTC330881
Director11 Nov 20192019₹4.33 Cr (FY 2025)Active
Designated Partner20 Jul 20222022Active
Dnb Hospitals Private Limited U85100MH2022PTC387183
Director20 Jul 20222022Active
Clinico Laboratory Private Limited U85300MH2022PTC387013
Director19 Jul 20222022Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director21 Nov 20242024Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Shree Pharmacy Llp
Clinico Scan Centre Private Limited
Clinico Pet Scan Private Limited
Dnb Hospitals Private Limited
Premium access

Shareholding and investment profile for Dimple Bhanushali

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Dimple Bhanushali

Dimple Bhanushali currently holds 5 directorships: Clinico Pet Scan Private Limited (Director, since 04 May 2021, revenue ₹10.59 Cr (FY 2025)); Clinico Scan Centre Private Limited (Director, since 11 Nov 2019, revenue ₹4.33 Cr (FY 2025)); Shree Pharmacy Llp (Designated Partner, since 20 Jul 2022); Dnb Hospitals Private Limited (Director, since 20 Jul 2022); Clinico Laboratory Private Limited (Director, since 19 Jul 2022).

Dimple Bhanushali was first appointed on 11 Nov 2019 as Director at Clinico Scan Centre Private Limited. The most recent appointment on record is 21 Nov 2024 at Benediction Healthcare Private Limited.

The 2 current companies of Dimple Bhanushali that report revenue have a combined latest revenue of ₹14.92 Cr: Clinico Pet Scan Private Limited ₹10.59 Cr (FY 2025); Clinico Scan Centre Private Limited ₹4.33 Cr (FY 2025).

Dimple Bhanushali held 1 earlier board appointment: Benediction Healthcare Private Limited (Director, 21 Nov 2024 to 10 Mar 2025).

The current boards of Dimple Bhanushali's companies include Ameya Milind Kasegaonkar (Clinico Pet Scan Private Limited), Amol Harikant Bhanushali (Clinico Pet Scan Private Limited), Arvind Salunke (Clinico Pet Scan Private Limited), Himanshu Kishor Desai (Clinico Pet Scan Private Limited), Kiran Ashok Patil (Clinico Pet Scan Private Limited), Rajani Sharma (Clinico Pet Scan Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available